Synthetic peptide conjugated to KLH, corresponding to a region within C terminal amino acids 1517-1547 of Human Kidins220 (Accessions: Q9ULH0, NP_065789.1)
Promotes a prolonged MAP-kinase signaling by neurotrophins through activation of a Rap1-dependent mechanism. Provides a docking site for the CRKL-C3G complex, resulting in Rap1-dependent sustained ERK activation. May play an important role in regulating postsynaptic signal transduction through the syntrophin-mediated localization of receptor tyrosine kinases such as EPHA4. In cooperation with SNTA1 can enhance EPHA4-induced JAK/STAT activation. May play a role in neurotrophin- and ephrin-mediated neuronal outgrowth and in axon guidance during neural development and in neuronal regeneration (By similarity). Modulates stress-induced apoptosis of melanoma cells via regulation of the MEK/ERK signaling pathway.
Pathway
ARMS-mediated activation; NGF signalling via TRKA from the plasma membrane; Neurotrophin signaling pathway; Prolonged ERK activation events; Signal Transduction; Signalling by NGF;
Citations
Publication ()
Have you cited DPABH-21876 in a publication? Let us know and earn a reward for your research.
My Review for Rabbit anti-Human Kidins220 polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.